لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Perez-Penco M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Schina A; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Siersbæk M; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Hübbe ML; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Jørgensen MA; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Lecoq I; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech ApS, Copenhagen, Denmark., Lara de la Torre L; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Bendtsen SK; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech ApS, Copenhagen, Denmark., Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Madsen DH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Ødum N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Grøntved L; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark Mads.Hald.Andersen@regionh.dk.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Dec; Vol. 10 (12).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines* , Pancreatic Neoplasms*/metabolism , Carcinoma, Pancreatic Ductal*/genetics, Mice ; Animals ; CD8-Positive T-Lymphocytes ; Transforming Growth Factor beta ; Tumor Microenvironment ; Disease Models, Animal ; Cell Line, Tumor ; Vaccines, Subunit/therapeutic use ; Mice, Inbred C57BL ; Immunosuppressive Agents/therapeutic use ; Immunity ; Fibrosis ; Pancreatic Neoplasms

المؤلفون: Klausen U; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark.; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Grauslund JH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark.; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Jørgensen NGD; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark.; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Ahmad SM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Jonassen M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Pedersen LB; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Lisle TL; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Gang AO; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Enggaard L; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Hansen M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Pedersen LM; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

المصدر: Frontiers in oncology [Front Oncol] 2022 Nov 22; Vol. 12, pp. 1023015. Date of Electronic Publication: 2022 Nov 22 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Weis-Banke SE; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Lisle TL; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Perez-Penco M; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Schina A; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Hübbe ML; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Siersbæk M; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Holmström MO; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Jørgensen MA; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Marie Svane I; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Met Ö; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Ødum N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Madsen DH; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Donia M; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Grøntved L; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Andersen MH; Department of Oncology, Herlev Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark Mads.Hald.Andersen@regionh.dk.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Oct; Vol. 10 (10).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes* , Neoplasms*, Humans ; Mice ; Animals ; T-Lymphocytes, Regulatory ; Arginase/metabolism ; Leukocytes, Mononuclear ; Histocompatibility Antigens Class I ; Interferon-gamma/metabolism ; Peptides/metabolism ; Tumor Microenvironment

المؤلفون: Kjeldsen JW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Lorentzen CL; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech Aps, Copenhagen, Denmark., Ellebaek E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Holmstroem RB; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Klausen TW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Madsen CO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Ahmed SM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hendel HW; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Herlev, Denmark., Ehrnrooth E; IO Biotech Aps, Copenhagen, Denmark., Zocca MB; IO Biotech Aps, Copenhagen, Denmark., Pedersen AW; IO Biotech Aps, Copenhagen, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. inge.marie.svane@regionh.dk.

المصدر: Nature medicine [Nat Med] 2022 Apr; Vol. 28 (4), pp. 871.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Bendtsen SK; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Perez-Penco M; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Hübbe ML; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Orebo Holmström M; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Grønne Dahlager Jørgensen N; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Jørgensen MA; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Munir Ahmad S; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Jensen KM; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Friese C; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Lundsager MT; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Johansen AZ; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Carretta M; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Ødum N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark., Madsen DH; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

المصدر: Oncoimmunology [Oncoimmunology] 2022 Jan 27; Vol. 11 (1), pp. 2026020. Date of Electronic Publication: 2022 Jan 27 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines* , Neoplasms*, Animals ; CD8-Positive T-Lymphocytes/metabolism ; Galectin 3/metabolism ; Humans ; Mice ; Tumor Microenvironment ; Vaccination ; Vaccines, Subunit

المؤلفون: Kjeldsen JW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Lorentzen CL; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech Aps, Copenhagen, Denmark., Ellebaek E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Holmstroem RB; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Klausen TW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Madsen CO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Ahmed SM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hendel HW; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Herlev, Denmark., Ehrnrooth E; IO Biotech Aps, Copenhagen, Denmark., Zocca MB; IO Biotech Aps, Copenhagen, Denmark., Pedersen AW; IO Biotech Aps, Copenhagen, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. inge.marie.svane@regionh.dk.

المصدر: Nature medicine [Nat Med] 2021 Dec; Vol. 27 (12), pp. 2212-2223. Date of Electronic Publication: 2021 Dec 09.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Adjuvants, Immunologic/*administration & dosage , B7-H1 Antigen/*immunology , Cancer Vaccines/*administration & dosage , Immune Checkpoint Inhibitors/*therapeutic use , Indoleamine-Pyrrole 2,3,-Dioxygenase/*immunology , Melanoma/*therapy , Nivolumab/*therapeutic use , Skin Neoplasms/*therapy, Humans ; Melanoma/pathology ; Skin Neoplasms/pathology

المؤلفون: Aaboe Jørgensen M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Ugel S; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., Linder Hübbe M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Carretta M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Perez-Penco M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech ApS, Copenhagen, Denmark., Kopp K; IO Biotech ApS, Copenhagen, Denmark., Chapellier M; IO Biotech ApS, Copenhagen, Denmark., Adamo A; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., De Sanctis F; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., Frusteri C; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., Iezzi M; Center for Advanced Studies and Technology (CAST), Department of Neurosciences Imaging and Clinical Sciences, University of G. D'Annunzio of Chieti-Pescara, Chieti, Italy., Zocca MB; IO Biotech ApS, Copenhagen, Denmark., Hargbøll Madsen D; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Wakatsuki Pedersen A; IO Biotech ApS, Copenhagen, Denmark., Bronte V; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. mads.hald.andersen@regionh.dk.; IO Biotech ApS, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

المصدر: Cancer immunology research [Cancer Immunol Res] 2021 Nov; Vol. 9 (11), pp. 1316-1326. Date of Electronic Publication: 2021 Sep 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Arginase/*metabolism , Myeloid Cells/*metabolism , Neoplasms/*drug therapy , Neoplasms/*immunology , Vaccines/*therapeutic use, Animals ; Cell Line, Tumor ; Female ; Humans ; Mice ; Tumor Microenvironment ; Vaccines/pharmacology ; Xenograft Model Antitumor Assays

المؤلفون: Klausen U; Dept. Of Hematology, Herlev Hospital, Herlev, Denmark.; Dept. Of Hematology, Rigshospitalet, Copenhagen, Denmark.; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen K, Denmark., Grønne Dahlager Jørgensen N; Dept. Of Hematology, Herlev Hospital, Herlev, Denmark.; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark., Grauslund JH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen K, Denmark., Munir Ahmad S; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark., Gang AO; Dept. Of Hematology, Rigshospitalet, Copenhagen, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark., Breinholt MF; Dept. Of Pathology, Herlev Hospital, Herlev, Denmark., Novotny GW; Dept. Of Hematology, Herlev Hospital, Herlev, Denmark.; Dept. Of Pathology, Herlev Hospital, Herlev, Denmark., Kjeldsen JW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen K, Denmark., Orebo Holmström M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen K, Denmark., Pedersen LB; Dept. Of Hematology, Rigshospitalet, Copenhagen, Denmark., Poulsen CB; Dept. Of Hematology, Zealand University Hospital, Roskilde, Rosklide, Denmark., Hansen PB; Dept. Of Hematology, Zealand University Hospital, Roskilde, Rosklide, Denmark., Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen K, Denmark., Niemann CU; Dept. Of Hematology, Rigshospitalet, Copenhagen, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen K, Denmark., Pedersen LM; Dept. Of Hematology, Herlev Hospital, Herlev, Denmark.; Dept. Of Hematology, Rigshospitalet, Copenhagen, Denmark.; Dept. Of Hematology, Zealand University Hospital, Roskilde, Rosklide, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology Herlev Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen K, Denmark.

المصدر: Oncoimmunology [Oncoimmunology] 2021 Sep 25; Vol. 10 (1), pp. 1975889. Date of Electronic Publication: 2021 Sep 25 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Handlos Grauslund J; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Jørgensen NG; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Klausen U; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., El Fassi D; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.; Department of Medicine, Copenhagen University, Copenhagen, Denmark., Schöllkopf C; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Clausen MB; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Gjerdrum LMR; Department of Pathology, Zealand University Hospital, Roskilde, Denmark., Breinholt MF; Department of Pathology, Copenhagen University Hospital, Herlev, Denmark., Kjeldsen JW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hansen M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Koschmieder S; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany., Chatain N; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany., Novotny GW; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Petersen J; Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Kjær L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Skov V; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark.

المصدر: Frontiers in oncology [Front Oncol] 2021 Feb 26; Vol. 11, pp. 637420. Date of Electronic Publication: 2021 Feb 26 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE